Toxic amyloid-β oligomers induced self-replication in astrocytes triggering neuronal injury

[1]  H. Molinari,et al.  Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity , 2018, Molecular Neurobiology.

[2]  R. Rao,et al.  Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH , 2018, Proceedings of the National Academy of Sciences.

[3]  E. Sigurdsson,et al.  Tau-targeting therapies for Alzheimer disease , 2018, Nature Reviews Neurology.

[4]  L. Tsai,et al.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.

[5]  Elizabeta Gjoneska,et al.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.

[6]  Hao Wang,et al.  A self-destructive nanosweeper that captures and clears amyloid β-peptides , 2018, Nature Communications.

[7]  M. Frosch,et al.  Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain , 2018, Acta Neuropathologica.

[8]  R. González-Reyes,et al.  Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective , 2017, Front. Mol. Neurosci..

[9]  G. Bu,et al.  ApoE4 Accelerates Early Seeding of Amyloid Pathology , 2017, Neuron.

[10]  Yue-Ming Li,et al.  The role of astrocytes in amyloid production and Alzheimer's disease , 2017, Open Biology.

[11]  A. Hamilton,et al.  Foldamer-Mediated Structural Rearrangement Attenuates Aβ Oligomerization and Cytotoxicity. , 2017, Journal of the American Chemical Society.

[12]  Yuan-zhao Sun,et al.  Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling , 2017, Neurobiology of Aging.

[13]  Haitao Guo,et al.  NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes , 2017, The Journal of experimental medicine.

[14]  U. Armato,et al.  Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143—Further Implications for Alzheimer's Therapy , 2017, Front. Neurosci..

[15]  D. Holtzman,et al.  Elucidating the Role of TREM2 in Alzheimer’s Disease , 2017, Neuron.

[16]  Fan Liao,et al.  Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease , 2016, Current opinion in lipidology.

[17]  B. de Strooper,et al.  Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons , 2016, Molecular Neurodegeneration.

[18]  E. Hol,et al.  Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease , 2016, Progress in Neurobiology.

[19]  J. Jia,et al.  Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[20]  B. Khakh,et al.  Diversity of astrocyte functions and phenotypes in neural circuits , 2015, Nature Neuroscience.

[21]  W. Klein,et al.  Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis , 2015, Acta Neuropathologica.

[22]  Marco Foddis,et al.  Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model , 2014, Nature Communications.

[23]  Amy M. Birch.  The contribution of astrocytes to Alzheimer's disease. , 2014, Biochemical Society transactions.

[24]  D. Holtzman,et al.  The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation , 2014, Biochemistry.

[25]  Daniel F Tardiff,et al.  Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity , 2014, Proceedings of the National Academy of Sciences.

[26]  Bengt Winblad,et al.  Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer’s disease , 2014, Acta Neuropathologica Communications.

[27]  C. Geula,et al.  A Lifespan Observation of a Novel Mouse Model: In Vivo Evidence Supports Aβ Oligomer Hypothesis , 2014, PloS one.

[28]  J. Macdonald,et al.  The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity , 2013, The Journal of Neuroscience.

[29]  Enzo Colarusso,et al.  Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease. , 2013, Biochimica et biophysica acta.

[30]  D. Holtzman,et al.  Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide , 2012, The Journal of Neuroscience.

[31]  A. Gillespie,et al.  Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice , 2012, The Journal of Neuroscience.

[32]  J. Jia,et al.  Val97Leu mutant presenilin‐1 induces tau hyperphosphorylation and spatial memory deficit in mice and the underlying mechanisms , 2012, Journal of neurochemistry.

[33]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[34]  R. Panush.  Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis , 2011 .

[35]  Yvonne S. Eisele,et al.  The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain , 2011, Acta Neuropathologica.

[36]  Frank Baumann,et al.  Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis , 2010, Science.

[37]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[38]  Gilles Bonvento,et al.  Targeted Activation of Astrocytes: A Potential Neuroprotective Strategy , 2008, Molecular Neurobiology.

[39]  J. Meldolesi,et al.  BACE1 Expression and Activity: Relevance in Alzheimer’s Disease , 2007, Neurodegenerative Diseases.

[40]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[41]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[42]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[43]  G. Leuba,et al.  Neuronal and Nonneuronal Quantitative BACE Immunocytochemical Expression in the Entorhinohippocampal and Frontal Regions in Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[44]  Jianmin Jia,et al.  One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[45]  S. Paul,et al.  Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.

[46]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.